Literature DB >> 22134580

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.

Bronson D Riley1, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy, Wendy C McKinnon, Nancie M Petrucelli, Robin L Bennett, Angela M Trepanier.   

Abstract

Updated from their original publication in 2004, these cancer genetic counseling recommendations describe the medical, psychosocial, and ethical ramifications of counseling at-risk individuals through genetic cancer risk assessment with or without genetic testing. They were developed by members of the Practice Issues Subcommittee of the National Society of Genetic Counselors Familial Cancer Risk Counseling Special Interest Group. The information contained in this document is derived from extensive review of the current literature on cancer genetic risk assessment and counseling as well as the personal expertise of genetic counselors specializing in cancer genetics. The recommendations are intended to provide information about the process of genetic counseling and risk assessment for hereditary cancer disorders rather than specific information about individual syndromes. Essential components include the intake, cancer risk assessment, genetic testing for an inherited cancer syndrome, informed consent, disclosure of genetic test results, and psychosocial assessment. These recommendations should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular outcome. These recommendations do not displace a health care provider's professional judgment based on the clinical circumstances of a client.

Entities:  

Mesh:

Year:  2011        PMID: 22134580     DOI: 10.1007/s10897-011-9462-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  70 in total

1.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

Review 2.  Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.

Authors:  G Geller; J R Botkin; M J Green; N Press; B B Biesecker; B Wilfond; G Grana; M B Daly; K Schneider; M J Kahn
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

Review 3.  Assessing women at high risk of breast cancer: a review of risk assessment models.

Authors:  Eitan Amir; Orit C Freedman; Bostjan Seruga; D Gareth Evans
Journal:  J Natl Cancer Inst       Date:  2010-04-28       Impact factor: 13.506

4.  Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Authors:  C Lerman; B Biesecker; J L Benkendorf; J Kerner; A Gomez-Caminero; C Hughes; M M Reed
Journal:  J Natl Cancer Inst       Date:  1997-01-15       Impact factor: 13.506

5.  Preimplantation genetic diagnosis for cancer predisposition syndromes.

Authors:  C Spits; M De Rycke; N Van Ranst; W Verpoest; W Lissens; A Van Steirteghem; I Liebaers; K Sermon
Journal:  Prenat Diagn       Date:  2007-05       Impact factor: 3.050

6.  The calculation of breast cancer risk for women with a first degree family history of ovarian cancer.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

7.  Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly Metcalfe; Henry T Lynch; Parviz Ghadirian; Nadine Tung; Ivo Olivotto; Ellen Warner; Olufunmilayo I Olopade; Andrea Eisen; Barbara Weber; Jane McLennan; Ping Sun; William D Foulkes; Steven A Narod
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

8.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

Review 9.  Cowden syndrome: a critical review of the clinical literature.

Authors:  Robert Pilarski
Journal:  J Genet Couns       Date:  2008-10-30       Impact factor: 2.537

10.  Increased genetic counseling support improves communication of genetic information in families.

Authors:  Laura E Forrest; Jo Burke; Sonya Bacic; David J Amor
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822

View more
  124 in total

Review 1.  Specific psychosocial issues of individuals undergoing genetic counseling for cancer - a literature review.

Authors:  Willem Eijzenga; Daniela E E Hahn; Neil K Aaronson; Irma Kluijt; Eveline M A Bleiker
Journal:  J Genet Couns       Date:  2013-08-31       Impact factor: 2.537

2.  From constraints to opportunities? Provision of psychosocial support in portuguese oncogenetic counseling services.

Authors:  Alvaro Mendes; Liliana Sousa; Milena Paneque
Journal:  J Genet Couns       Date:  2013-08-30       Impact factor: 2.537

3.  Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals.

Authors:  Cristi Radford; Anya Prince; Karen Lewis; Tuya Pal
Journal:  J Genet Couns       Date:  2013-12-04       Impact factor: 2.537

4.  A model for patient-direct screening and referral for familial cancer risk.

Authors:  Kristin B Niendorf; Melissa A Geller; Rachel Isaksson Vogel; Timothy R Church; Anna Leininger; Angela Bakke; Robert D Madoff
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

5.  Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.

Authors:  C L Scherr; N M Lindor; T L Malo; F J Couch; S T Vadaparampil
Journal:  Clin Genet       Date:  2015-02-26       Impact factor: 4.438

Review 6.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

7.  Breast Cancer Survivors' Knowledge of Hereditary Breast and Ovarian Cancer following Genetic Counseling: An Exploration of General and Survivor-Specific Knowledge Items.

Authors:  Courtney L Scherr; Juliette Christie; Susan T Vadaparampil
Journal:  Public Health Genomics       Date:  2015-09-22       Impact factor: 2.000

8.  Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.

Authors:  J O Culver; C D Brinkerhoff; J Clague; K Yang; K E Singh; S R Sand; J N Weitzel
Journal:  Clin Genet       Date:  2013-02-20       Impact factor: 4.438

Review 9.  Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.

Authors:  Georgios Kallinikas; Helai Habib; Dimitrios Tsimiliotis; Evangelos Koutsokostas; Barna Bokor
Journal:  Int Urol Nephrol       Date:  2017-05-31       Impact factor: 2.370

10.  Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?

Authors:  Deborah Cragun; Courtney Scherr; Lucia Camperlengo; Susan T Vadaparampil; Tuya Pal
Journal:  Genet Test Mol Biomarkers       Date:  2016-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.